Galapagos/€GLPG
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Galapagos
Galapagos NV, abbreviated as GLPG on stock exchanges, is a global biotechnology firm specializing in the discovery and development of small molecule medicines. The company focuses on innovating treatments primarily in the fields of immunology and oncology. Founded in 1999, Galapagos operates out of its headquarters in Belgium and extends its reach across Europe and the United States, aiming to provide transformative therapies for significant unmet medical needs.
Ticker
€GLPG
Sector
Primary listing
AEX
Employees
704
Headquarters
Website
Galapagos Metrics
BasicAdvanced
€1.9B
5.86
€4.87
0.10
-
Price and volume
Market cap
€1.9B
Beta
0.1
52-week high
€32.64
52-week low
€20.00
Average daily volume
5K
Financial strength
Current ratio
20.145
Quick ratio
19.952
Long term debt to equity
0.16
Total debt to equity
0.214
Profitability
Gross margin (TTM)
57.49%
Net profit margin (TTM)
28.85%
Effective tax rate (TTM)
-6.19%
Revenue per employee (TTM)
€1,580,000
Management effectiveness
Return on assets (TTM)
8.58%
Return on equity (TTM)
10.42%
Valuation
Price to earnings (TTM)
5.864
Price to revenue (TTM)
1.692
Price to book
0.59
Price to tangible book (TTM)
0.59
Price to free cash flow (TTM)
-6.936
Free cash flow yield (TTM)
-14.42%
Free cash flow per share (TTM)
-4.118
Growth
Revenue change (TTM)
303.50%
Earnings per share change (TTM)
334.82%
3-year revenue growth (CAGR)
66.44%
10-year revenue growth (CAGR)
33.78%
3-year earnings per share growth (CAGR)
13.61%
10-year earnings per share growth (CAGR)
3.91%
What the Analysts think about Galapagos
Analyst ratings (Buy, Hold, Sell) for Galapagos stock.
Galapagos Financial Performance
Revenues and expenses
Galapagos Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Galapagos stock?
Galapagos (GLPG) has a market cap of €1.9B as of March 07, 2026.
What is the P/E ratio for Galapagos stock?
The price to earnings (P/E) ratio for Galapagos (GLPG) stock is 5.86 as of March 07, 2026.
Does Galapagos stock pay dividends?
No, Galapagos (GLPG) stock does not pay dividends to its shareholders as of March 07, 2026.
When is the next Galapagos dividend payment date?
Galapagos (GLPG) stock does not pay dividends to its shareholders.
What is the beta indicator for Galapagos?
Galapagos (GLPG) has a beta rating of 0.1. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.